John Tomayko

Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States

Teresa M. Coque, John Tomayko, Steven C. Ricke et al. · Antimicrobial Agents and Chemotherapy · 1996 · 280 citations · Full text

Gastroenterology, Pathology, Veterinary Microbiology +19

A comprehensive regulatory framework to address the unmet need for new antibacterial treatments

John Rex, Barry I. Eisenstein, Jeff Alder et al. · The Lancet Infectious Diseases · 2013 · 119 citations

Antimicrobial Susceptibility, New Antibacterial Treatments, Antibiotics +10

Bacterial Resistance to Leucyl-tRNA Synthetase Inhibitor GSK2251052 Develops during Treatment of Complicated Urinary Tract Infections

Karen O’Dwyer, Aaron Spivak, Karen Ingraham et al. · Antimicrobial Agents and Chemotherapy · 2014 · 97 citations · Full text

Microbial Pathogens, Escherichia Coli Isolates, Antibiotic Resistance +21

Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: Results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial

R. Phillip Dellinger, John Tomayko, Derek C. Angus et al. · Critical Care Medicine · 2009 · 76 citations

Analysis of Enterococcus faecalis isolates from intercontinental sources by multilocus enzyme electrophoresis and pulsed-field gel electrophoresis

John Tomayko, B E Murray · Journal of Clinical Microbiology · 1995 · 57 citations · Full text

Pathogenic Microbiology, Pathogen Detection, Klebsiella Pneumoniae +16